Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | cAMP phosphodiesterase A, putative | 0.0063 | 0.014 | 0.1151 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0063 | 0.014 | 0.1151 |
Trichomonas vaginalis | high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0226 | 0.0967 | 1 |
Trypanosoma brucei | cAMP-specific phosphodiesterase, putative | 0.0063 | 0.014 | 0.1151 |
Toxoplasma gondii | 3'5'-cyclic nucleotide phosphodiesterase domain-containing protein | 0.0064 | 0.0143 | 0.0073 |
Brugia malayi | Probable 3',5'-cyclic phosphodiesterase R153.1, putative | 0.0063 | 0.014 | 0.0069 |
Trypanosoma brucei | thymidylate kinase, putative | 0.0138 | 0.0522 | 0.524 |
Echinococcus multilocularis | calcium:calmodulin dependent 3',5' cyclic | 0.0063 | 0.014 | 0.014 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0063 | 0.014 | 0.1151 |
Loa Loa (eye worm) | PDE1B protein | 0.0063 | 0.014 | 0.0144 |
Loa Loa (eye worm) | hypothetical protein | 0.0063 | 0.014 | 0.0144 |
Echinococcus granulosus | cAMP specific 3'5' cyclic phosphodiesterase | 0.0063 | 0.014 | 0.014 |
Trypanosoma cruzi | cAMP specific phosphodiesterase, putative | 0.0226 | 0.0967 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0063 | 0.014 | 0.1151 |
Echinococcus multilocularis | high affinity cAMP specific 3',5' cyclic | 0.0063 | 0.014 | 0.014 |
Brugia malayi | cation channel family protein | 0.0075 | 0.0204 | 0.0134 |
Mycobacterium ulcerans | putative regulatory protein | 0.0163 | 0.0648 | 0.0279 |
Schistosoma mansoni | hypothetical protein | 0.0138 | 0.0522 | 0.5278 |
Trichomonas vaginalis | cAMP/cGMP cyclic nucleotide phosphodiesterase, putative | 0.0226 | 0.0967 | 1 |
Trypanosoma cruzi | cAMP specific phosphodiesterase, putative | 0.0226 | 0.0967 | 1 |
Schistosoma mansoni | calcium/calmodulin-dependent 35-cyclic nucleotide phosphodiesterase | 0.0063 | 0.014 | 0.1221 |
Trypanosoma brucei | cAMP-specific phosphodiesterase | 0.0226 | 0.0967 | 1 |
Trichomonas vaginalis | cyclic nucleotide phosphodiesterase, putative | 0.0226 | 0.0967 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0063 | 0.014 | 0.1151 |
Schistosoma mansoni | high-affinity cgmp-specific 35-cyclic phosphodiesterase | 0.0063 | 0.014 | 0.1221 |
Plasmodium falciparum | GAF domain-related protein, putative | 0.0163 | 0.0648 | 1 |
Trichomonas vaginalis | cGMP-dependent 3,5-cyclic phosphodiesterase, putative | 0.0226 | 0.0967 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0226 | 0.0967 | 1 |
Trichomonas vaginalis | cAMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0226 | 0.0967 | 1 |
Trichomonas vaginalis | thymidylate kinase, putative | 0.0138 | 0.0522 | 0.4621 |
Trichomonas vaginalis | high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0226 | 0.0967 | 1 |
Trypanosoma brucei | thymidylate kinase, putative | 0.0138 | 0.0522 | 0.524 |
Echinococcus multilocularis | calcium:calmodulin dependent 3',5' cyclic | 0.0063 | 0.014 | 0.014 |
Brugia malayi | thymidylate kinase | 0.0138 | 0.0522 | 0.0454 |
Toxoplasma gondii | 3'5'-cyclic nucleotide phosphodiesterase domain-containing protein | 0.0064 | 0.0143 | 0.0073 |
Treponema pallidum | thymidylate kinase (tmk) | 0.0138 | 0.0522 | 0.5 |
Trichomonas vaginalis | calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative | 0.0226 | 0.0967 | 1 |
Schistosoma mansoni | camp-specific 35-cyclic phosphodiesterase | 0.0063 | 0.014 | 0.1221 |
Plasmodium vivax | thymidylate kinase, putative | 0.0138 | 0.0522 | 0.7524 |
Trichomonas vaginalis | cGMP-inhibited 3,5-cyclic phosphodiesterase, putative | 0.0226 | 0.0967 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0063 | 0.014 | 0.0144 |
Trypanosoma cruzi | cyclic nucleotide phosphodiesterase | 0.0063 | 0.014 | 0.1151 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0163 | 0.0648 | 0.6141 |
Loa Loa (eye worm) | hypothetical protein | 0.0047 | 0.006 | 0.0062 |
Mycobacterium ulcerans | two component sensor histidine kinase DevS | 0.0163 | 0.0648 | 0.0279 |
Leishmania major | hypothetical protein, conserved | 0.0063 | 0.014 | 0.0504 |
Mycobacterium tuberculosis | Two component sensor histidine kinase DosT | 0.0163 | 0.0648 | 0.0279 |
Schistosoma mansoni | camp-specific 35-cyclic phosphodiesterase | 0.0063 | 0.014 | 0.1221 |
Trichomonas vaginalis | rod cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0226 | 0.0967 | 1 |
Toxoplasma gondii | GAF domain-containing protein | 0.0163 | 0.0648 | 1 |
Echinococcus granulosus | calcium:calmodulin dependent 3'5' cyclic | 0.0063 | 0.014 | 0.014 |
Trichomonas vaginalis | cAMP-specific phosphodiesterase, putative | 0.0226 | 0.0967 | 1 |
Mycobacterium leprae | conserved hypothetical protein | 0.0163 | 0.0648 | 0.164 |
Schistosoma mansoni | camp/cgmp cyclic nucleotide phosphodiesterase | 0.0226 | 0.0967 | 1 |
Schistosoma mansoni | camp-specific 35-cyclic phosphodiesterase | 0.0063 | 0.014 | 0.1221 |
Trichomonas vaginalis | high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0226 | 0.0967 | 1 |
Schistosoma mansoni | camp-specific cyclic nucleotide phosphodiesterase | 0.0063 | 0.014 | 0.1221 |
Giardia lamblia | CDC8 | 0.0138 | 0.0522 | 1 |
Trichomonas vaginalis | cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0226 | 0.0967 | 1 |
Trichomonas vaginalis | thymidylate kinase, putative | 0.0138 | 0.0522 | 0.4621 |
Trichomonas vaginalis | cGMP-dependent 3,5-cyclic phosphodiesterase, putative | 0.0226 | 0.0967 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0163 | 0.0648 | 0.6141 |
Trichomonas vaginalis | cone cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0226 | 0.0967 | 1 |
Trichomonas vaginalis | cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0226 | 0.0967 | 1 |
Schistosoma mansoni | camp-specific 35-cyclic phosphodiesterase | 0.0063 | 0.014 | 0.1221 |
Brugia malayi | 3'5'-cyclic nucleotide phosphodiesterase family protein | 0.0063 | 0.014 | 0.0069 |
Echinococcus granulosus | calcium:calmodulin dependent 3'5' cyclic | 0.0063 | 0.014 | 0.014 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.0025 | 0.0026 |
Echinococcus granulosus | cAMP specific 3'5' cyclic phosphodiesterase | 0.0063 | 0.014 | 0.014 |
Toxoplasma gondii | hypothetical protein | 0.0163 | 0.0648 | 1 |
Trichomonas vaginalis | cGMP-dependent 3,5-cyclic phosphodiesterase, putative | 0.0226 | 0.0967 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0063 | 0.014 | 0.1151 |
Mycobacterium ulcerans | thymidine phosphorylase | 0.1024 | 0.5021 | 1 |
Echinococcus multilocularis | cAMP specific 3',5' cyclic phosphodiesterase | 0.0063 | 0.014 | 0.014 |
Trypanosoma cruzi | cAMP-specific phosphodiesterase, putative | 0.0063 | 0.014 | 0.1151 |
Echinococcus granulosus | thymidylate kinase | 0.0138 | 0.0522 | 0.0522 |
Wolbachia endosymbiont of Brugia malayi | thymidylate kinase | 0.0138 | 0.0522 | 0.5 |
Mycobacterium ulcerans | anthranilate phosphoribosyltransferase | 0.0289 | 0.1289 | 0.1704 |
Loa Loa (eye worm) | hypothetical protein | 0.0063 | 0.014 | 0.0144 |
Mycobacterium leprae | Probable anthranilate phosphoribosyltransferase TrpD | 0.0289 | 0.1289 | 1 |
Trypanosoma cruzi | cAMP specific phosphodiesterase, putative | 0.0226 | 0.0967 | 1 |
Mycobacterium ulcerans | putative regulatory protein | 0.0163 | 0.0648 | 0.0279 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.0065 | 0.0067 |
Echinococcus granulosus | high affinity cAMP specific 3'5' cyclic | 0.0063 | 0.014 | 0.014 |
Brugia malayi | Probable 3',5'-cyclic phosphodiesterase T04D3.3, putative | 0.0063 | 0.014 | 0.0069 |
Echinococcus granulosus | dual 3'5' cyclic AMP and GMP phosphodiesterase | 0.0226 | 0.0967 | 0.0967 |
Trypanosoma brucei | cAMP phosphodiesterase A, putative | 0.0063 | 0.014 | 0.1151 |
Echinococcus granulosus | high affinity cgmp specific 3' 5' cyclic | 0.0063 | 0.014 | 0.014 |
Chlamydia trachomatis | thymidylate kinase | 0.0138 | 0.0522 | 0.5 |
Trichomonas vaginalis | cyclic nucleotide phosphodiesterase, putative | 0.0226 | 0.0967 | 1 |
Mycobacterium tuberculosis | Probable anthranilate phosphoribosyltransferase TrpD | 0.0289 | 0.1289 | 0.1704 |
Schistosoma mansoni | high-affinity cgmp-specific 35-cyclic phosphodiesterase | 0.0063 | 0.014 | 0.1221 |
Trichomonas vaginalis | calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative | 0.0226 | 0.0967 | 1 |
Trichomonas vaginalis | cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0226 | 0.0967 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0163 | 0.0648 | 0.6141 |
Trichomonas vaginalis | cAMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0226 | 0.0967 | 1 |
Toxoplasma gondii | hypothetical protein | 0.0163 | 0.0648 | 1 |
Leishmania major | thymidylate kinase-like protein | 0.0138 | 0.0522 | 0.4892 |
Echinococcus multilocularis | cAMP and cAMP inhibited cGMP 3',5' cyclic | 0.2004 | 1 | 1 |
Toxoplasma gondii | thymidylate kinase | 0.0138 | 0.0522 | 0.7524 |
Brugia malayi | 3'5'-cyclic nucleotide phosphodiesterase family protein | 0.0063 | 0.014 | 0.0069 |
Trypanosoma brucei | cAMP-specific phosphodiesterase | 0.0226 | 0.0967 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0063 | 0.014 | 0.1151 |
Trypanosoma cruzi | cAMP specific phosphodiesterase, putative | 0.0063 | 0.014 | 0.1151 |
Echinococcus multilocularis | dual 3',5' cyclic AMP and GMP phosphodiesterase | 0.0226 | 0.0967 | 0.0967 |
Echinococcus multilocularis | thymidine phosphorylase | 0.1024 | 0.5021 | 0.5021 |
Schistosoma mansoni | thymidylate kinase | 0.0138 | 0.0522 | 0.5278 |
Trypanosoma cruzi | thymidylate kinase, putative | 0.0138 | 0.0522 | 0.524 |
Trichomonas vaginalis | high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0226 | 0.0967 | 1 |
Trichomonas vaginalis | rod cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0226 | 0.0967 | 1 |
Leishmania major | cAMP-specific phosphodiesterase, putative | 0.0063 | 0.014 | 0.0504 |
Schistosoma mansoni | cgmp-dependent 35-cyclic phosphodiesterase | 0.0226 | 0.0967 | 1 |
Trichomonas vaginalis | cAMP-specific phosphodiesterase, putative | 0.0226 | 0.0967 | 1 |
Trichomonas vaginalis | high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0226 | 0.0967 | 1 |
Leishmania major | cAMP phosphodiesterase A, putative;with=GeneDB:LinJ18_V3.1100 | 0.0063 | 0.014 | 0.0504 |
Loa Loa (eye worm) | thymidylate kinase | 0.0138 | 0.0522 | 0.0539 |
Trypanosoma cruzi | thymidylate kinase, putative | 0.0138 | 0.0522 | 0.524 |
Entamoeba histolytica | Thymidylate kinase, putative | 0.0138 | 0.0522 | 0.5 |
Plasmodium falciparum | thymidylate kinase | 0.0138 | 0.0522 | 0.7524 |
Mycobacterium tuberculosis | Two component sensor histidine kinase DevS | 0.0163 | 0.0648 | 0.0279 |
Echinococcus granulosus | cAMP and cAMP inhibited cGMP 3'5' cyclic | 0.2004 | 1 | 1 |
Trypanosoma brucei | 3', 5'-cyclic nucleotide phosphodiesterase, putative | 0.0063 | 0.014 | 0.1151 |
Trypanosoma cruzi | UMP-CMP kinase, mitochondrial, putative | 0.0054 | 0.0096 | 0.0681 |
Loa Loa (eye worm) | calcium/calmodulin-stimulated cyclic nucleotide phosphodiesterase | 0.0063 | 0.014 | 0.0144 |
Schistosoma mansoni | ryanodine receptor related | 0.0049 | 0.0071 | 0.0496 |
Echinococcus multilocularis | high affinity cgmp specific 3' 5' cyclic | 0.0063 | 0.014 | 0.014 |
Trichomonas vaginalis | rod cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0226 | 0.0967 | 1 |
Schistosoma mansoni | high-affinity cgmp-specific 35-cyclic phosphodiesterase | 0.0063 | 0.014 | 0.1221 |
Echinococcus multilocularis | cAMP specific 3',5' cyclic phosphodiesterase | 0.0063 | 0.014 | 0.014 |
Schistosoma mansoni | thymidylate kinase | 0.0138 | 0.0522 | 0.5278 |
Schistosoma mansoni | inositol 145-trisphosphate receptor | 0.0061 | 0.0133 | 0.1146 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0163 | 0.0648 | 0.6141 |
Trypanosoma brucei | 3', 5'-cyclic nucleotide phosphodiesterase, putative | 0.0063 | 0.014 | 0.1151 |
Brugia malayi | 3'5'-cyclic nucleotide phosphodiesterase family protein | 0.0226 | 0.0967 | 0.0902 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0063 | 0.014 | 0.1151 |
Loa Loa (eye worm) | hypothetical protein | 0.1941 | 0.9681 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.1778 | 0.8854 | 0.9146 |
Plasmodium vivax | hypothetical protein, conserved | 0.0163 | 0.0648 | 1 |
Echinococcus granulosus | thymidine phosphorylase | 0.1024 | 0.5021 | 0.5021 |
Trichomonas vaginalis | cone cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0226 | 0.0967 | 1 |
Trichomonas vaginalis | calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative | 0.0226 | 0.0967 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0063 | 0.014 | 0.0504 |
Trichomonas vaginalis | calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative | 0.0226 | 0.0967 | 1 |
Trypanosoma cruzi | UMP-CMP kinase, mitochondrial, putative | 0.0054 | 0.0096 | 0.0681 |
Loa Loa (eye worm) | hypothetical protein | 0.0226 | 0.0967 | 0.0999 |
Mycobacterium tuberculosis | Probable thymidine phosphorylase DeoA (tdrpase) (pyrimidine phosphorylase) | 0.1024 | 0.5021 | 1 |
Trypanosoma cruzi | cAMP phosphodiesterase A, putative | 0.0063 | 0.014 | 0.1151 |
Trichomonas vaginalis | calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative | 0.0226 | 0.0967 | 1 |
Toxoplasma gondii | hypothetical protein | 0.0163 | 0.0648 | 1 |
Trichomonas vaginalis | cyclic nucleotide phosphodiesterase, putative | 0.0226 | 0.0967 | 1 |
Onchocerca volvulus | Putative thymidylate kinase | 0.0138 | 0.0522 | 0.5 |
Trichomonas vaginalis | calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative | 0.0226 | 0.0967 | 1 |
Echinococcus multilocularis | thymidylate kinase | 0.0138 | 0.0522 | 0.0522 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.